NCT00727454

Brief Summary

Obstructive sleep apnea (OSA) is independently associated with important heart remodeling that further contributes to overt heart failure. Recent evidences using echocardiogram suggested that continuous positive airway pressure (CPAP) has beneficial effects mainly on left ventricle parameters. However, the evidences regarding the right ventricle are scanty. In addition, no previous studies evaluated morphological and functional characteristics in OSA by magnetic resonance imaging (MRI) as well as the impact of CPAP.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jul 2007

Longer than P75 for phase_4

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 4, 2008

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

November 18, 2014

Status Verified

November 1, 2014

Enrollment Period

3.3 years

First QC Date

July 28, 2008

Last Update Submit

November 14, 2014

Conditions

Keywords

Obstructive sleep apneaCPAPHeart remodelingCardiovascular diseaseMRI

Outcome Measures

Primary Outcomes (1)

  • Right ventricle parameters: size and function.

    Baseline and after 3 months.

Secondary Outcomes (1)

  • Left Ventricle parameters: size and function

    Baseline and after 3 months.

Study Arms (2)

1 Control

PLACEBO COMPARATOR

No treatment

Device: No treatment

2 CPAP

EXPERIMENTAL

Continuous Positive Airway Pressure (CPAP) - REMStar Pro with C-Flex; Respironics, Inc., Murrysville, PA

Device: CPAP

Interventions

CPAPDEVICE

Continuous Positive Airway Pressure (CPAP) during sleep for 3 months.

Also known as: CPAP REMStar Pro with C-Flex; Respironics, Inc.
2 CPAP

No treatment

1 Control

Eligibility Criteria

Age30 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients free of comorbidities with severe Obstructive Sleep Apnea by polysomnography.
  • Healthy volunteers (no obstructive sleep apnea and no comorbidities) matched for age, sex and body mass index.

You may not qualify if:

  • Subjects older than 60 years
  • Body mass index (BMI) \>40 kg/m2
  • Diabetes mellitus
  • Hypertension
  • Cerebrovascular disease
  • Valvular heart disease
  • Renal failure
  • Current or past smoking history
  • Chronic use of any medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Heart Institute (InCor) - University of São Paulo Medical School

São Paulo, São Paulo, 05403-904, Brazil

Location

Heart Institute (InCor)

São Paulo, São Paulo, 05403-904, Brazil

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveCardiovascular Diseases

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Luciano F Drager, MD, PhD

    Hypertension Unit, Heart Institute (InCor)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Luciano F. Drager

Study Record Dates

First Submitted

July 28, 2008

First Posted

August 4, 2008

Study Start

July 1, 2007

Primary Completion

October 1, 2010

Study Completion

December 1, 2010

Last Updated

November 18, 2014

Record last verified: 2014-11

Locations